Iskalni niz:
išči po
išči po
išči po
išči po
Vrsta gradiva:
Jezik:
Št. zadetkov: 5
Izvirni znanstveni članek
Oznake: kristalizacija;velikost delcev;Taguchi metoda;crystallization;particle size;Taguchi method;
Crystallization has become one of the most important unit operation in the chemical industries. The need to reduce the time from product discovery to market introduction is an inherent concern. In order to achieve the prescribedproduct quality characteristics, the process of engineering experimentat ...
Leto: 2004 Vir: Fakulteta za kemijo in kemijsko tehnologijo (UM FKKT)
Diplomsko delo
Oznake: kemija;termodifuzijska tehnika;procesna tehnika;ekstrakcija;superkritični fluidi;fazno ravnotežje;modeliranje;Peng-Robinsonova enačba stanja;CPA EoS;process tehnics;extraction;supercritical fluids;phase equilibrium;modelling;Peng-Robinson equation of state;
Removal of organic polutants from wastewater using supercritical fluid : diploma
Leto: 2001 Vir: Fakulteta za kemijo in kemijsko tehnologijo (UM FKKT)
Patentna prijava
Oznake: patentne prijave;O-dezmetil-venlafaksin;farmacevtska industrija;
The present invention relates to a process for the preparation of a salt of O-desmethylvenlafaxine comprising a) dissolving or suspending O-desmethylvenlafaxine in the form of its base in a liquid medium selected from the group of solvents and suspending agents; b) contacting O-desmethylvenlafaxine ...
Leto: 2009 Vir: Fakulteta za farmacijo (UL FFA)
Patentna prijava
Oznake: patentne prijave;O-dezmetil-venlafaksin;farmacevtska industrija;
The present invention relates to a process for the preparation of a salt of O-desmethylvenlafaxine comprising a) dissolving or suspending O-desmethylvenlafaxine in the form of its base in a liquid medium selected from the group of solvents and suspending agents,- b) contacting O-desmethylvenlafaxine ...
Leto: 2009 Vir: Fakulteta za farmacijo (UL FFA)
Patentna prijava
Oznake: patenti;ziprasidon sulfat;farmacevtske formulacije;polimorfne oblike;farmacevtska tehnologija;
The present invention relates to novel polymorphic forms of Ziprasidone sulfates Ziprasidone Hn+ X Z H2O wherein Ziprasidone is a compound of the formula; H is hydrogen; n is 1 or 2; 2- X is HSO4- or SO42-; and Z is O to 30., as well as to a process for their preparation and pharmaceutical formulati ...
Leto: 2008 Vir: Fakulteta za farmacijo (UL FFA)
Št. zadetkov: 5
Ključne besede:





Leto izdaje:


Avtorji:





Repozitorij:
Tipologija:

Jezik: